NeuroOne Medical Technolo...

NASDAQ: NMTC · Real-Time Price · USD
0.83
0.00 (0.00%)
At close: Aug 15, 2025, 12:15 PM

NeuroOne Medical Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
1.39M 3.27M 272.28K 825.78K 1.38M 977.65K 741.78K 629.91K 466.18K 114.58K 68.79K 32.05K 36.58K 33.75K 48.34K 40.1K 18.24K 71.47K
Cost of Revenue
615.49K 1.35M 131.22K 543.9K 986.88K 711.34K 548.13K 386.24K 434.67K 126.89K 83.85K 38.46K 72.81K 46.84K 65.47K 61.94K 39.36K 109.13K
Gross Profit
771.06K 1.93M 141.06K 281.87K 390.42K 266.31K 193.66K 243.67K 31.5K -12.31K -15.06K -6.41K -36.22K -13.1K -17.13K -21.84K -21.12K -37.66K
Operating Income
-2.68M 1.71M -2.82M -2.79M -2.89M -3.39M -3.16M -3.51M -3.5M -1.78M -1.4M -2.76M -3.06M -2.81M -2.64M -3.03M -2.4M -2.14M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-2.27M 1.79M -3.35M -2.77M -2.86M -3.34M -3.14M -3.47M -3.52M -1.73M -1.37M -2.76M -3.06M -2.81M -2.64M -2.95M -2.39M -1.96M
Net Income
-2.27M 1.79M -3.35M -2.77M -2.86M -3.34M -3.14M -3.47M -3.52M -1.73M -1.37M -2.76M -3.06M -2.81M -2.64M -2.95M -2.39M -1.96M
Selling & General & Admin
1.94M 2.04M 1.84M 1.88M 2M 2.17M 1.58M 1.86M 1.82M 1.66M 1.89M 1.53M 1.82M 1.74M 1.62M 2.13M 1.31M 1.19M
Research & Development
1.51M 1.17M 1.11M 1.19M 1.27M 1.48M 1.78M 1.89M 1.71M 1.56M 1.44M 1.23M 1.21M 1.06M 1.01M 901.13K 1.08M 934.16K
Other Expenses
n/a -3M n/a n/a 31.01K n/a 29.62K n/a n/a 51.58K 25.85K 1.71K 1.74K 1.85K 960.00 n/a 1.77K 185K
Operating Expenses
3.45M 215.68K 2.96M 3.08M 3.28M 3.66M 3.36M 3.75M 3.53M 1.77M 1.39M 2.76M 3.02M 2.8M 2.63M 3.01M 2.37M 2.11M
Interest Expense
n/a 324.74K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.05K
Selling & Marketing Expenses
n/a n/a -110.05K 45K 15.78K 49.27K 17.3K 49.49K 53.61K 53.03K 52.6K 43.48K 113.2K 61.34K 117.43K 79.26K 113.14K n/a
Cost & Expenses
4.07M 1.56M 3.09M 3.62M 4.26M 4.37M 3.91M 4.14M 3.96M 1.9M 1.47M 2.79M 3.1M 2.84M 2.69M 3.08M 2.41M 2.21M
Income Tax Expense
n/a n/a n/a n/a n/a 3.00 18.7K n/a n/a -5.7K n/a -27.11K -26.67K -26.23K 960.00 n/a 1.77K n/a
Shares Outstanding (Basic)
31.11M 30.84M 26.76M 27.35M 25.91M 24M 23.52M 17.58M 16.41M 16.23M 16.22M 16.19M 16.19M 15.41M 12.01M 11.96M 11.24M 7.68M
Shares Outstanding (Diluted)
31.11M 30.88M 26.76M 27.35M 25.91M 24M 23.52M 17.58M 16.41M 16.23M 16.22M 16.19M 16.19M 15.41M 12.01M 11.96M 11.24M 7.68M
EPS (Basic)
-0.07 0.06 0.34 -0.1 -0.11 -0.14 -0.13 -0.2 -0.21 -0.11 -0.08 -0.17 -0.19 -0.18 -0.22 -0.25 -0.21 -0.26
EPS (Diluted)
-0.07 0.06 0.34 -0.1 -0.11 -0.14 -0.13 -0.2 -0.21 -0.11 -0.08 -0.17 -0.19 -0.18 -0.22 -0.25 -0.21 -0.26
EBITDA
-2.2M 2.18M -2.95M -2.73M -2.83M -3.33M -3.1M -3.45M -3.45M -1.75M -1.34M -2.73M -3.03M -2.78M -2.58M -2.92M -2.37M -1.92M
EBIT
-2.27M 2.11M -3.02M -2.79M -2.89M -3.39M -3.16M -3.51M -3.5M -1.78M -1.37M -2.76M -3.06M -2.81M -2.64M -2.95M -2.39M -1.96M
Depreciation & Amortization
65.63K 65.13K -182.66K 63.11K 60.9K 58.66K 62.51K 56.96K 43.91K 35.89K 60.99K 58.62K 55.2K 51.4K 58.85K 29.03K 26.67K 18.74K